Marina Bay Sands, Singapore November 22–24, 2026 [email protected] +65 6000 1234
CPD Accredited
ICPOC 2026 Conference
International Oncology Conference

International Cancer &
Precision Oncology
Conference 2026

Nov 22–24, 2026 Marina Bay Sands, Singapore 1,500+ Attendees Expected

Advancing global oncology through collaboration, innovation, and precision medicine. Join 1,500+ clinicians and researchers from 50+ countries.

Early Bird Ends
September 15, 2026
Save up to 30% · Group discounts available
CPD Accredited Event
15+ CME Credits
Certified by JACCPD · Globally recognised
Dates: November 22–24, 2026
Venue: Marina Bay Sands Convention Centre
Abstract Deadline: August 30, 2026
Format: In-Person & Virtual (Hybrid)
Conference starts in:
000
Days
:
00
Hours
:
00
Minutes
:
00
Seconds

0

CPD Accredited
CME Credits

0

Expected
Attendees

0

Countries
Represented

0

Expert
Speakers

ICPOC 2026 – Hybrid Edition

The International Cancer and Precision Oncology Conference (ICPOC) is the premier global forum for oncologists, researchers, and clinical scientists dedicated to advancing cancer care through innovation and collaboration. Now in its sixth edition, ICPOC 2026 brings together the brightest minds in oncology to discuss cutting-edge research, emerging therapies, and precision medicine breakthroughs.

Held at the iconic Marina Bay Sands Convention Centre, Singapore, the conference spans three intensive days of plenary lectures, workshops, abstract presentations, and networking events. This year's hybrid format ensures that clinicians and scientists unable to attend in person can still participate fully.

Abstract Submission Deadline
August 30, 2026
Submit your abstract →
Early Bird Ends
September 15, 2026
Register now & save 30% →

Research Focus Areas

Submit your research under one of our curated scientific themes. Click a topic to learn more.

Topic 01

Cancer Genetics & Diagnosis

Genomic profiling, biomarkers, liquid biopsy, AI-driven diagnostics.

Topic 02

Haematology & Haematological Oncology

Leukaemia, lymphoma, myeloma, CAR-T cell therapy advances.

Topic 03

Case Reports

Rare and complex oncology cases with clinical insights and outcomes.

Topic 04

Cancer Treatment

Immunotherapy, targeted therapy, radiation, combination regimens.

Topic 05

Oncology Nursing & Allied Health

Nursing practice, patient navigation, multidisciplinary team care.

Topic 06

Palliative Care & Supportive Oncology

Symptom management, quality of life, end-of-life care frameworks.

Topic 07

Cancer Research & Clinical Trials

Phase I–IV trials, translational research, evidence-based practice.

Topic 08

Survivorship & Long-Term Care

Post-treatment surveillance, psychological well-being, rehabilitation.

Leadership & Governance

Visionary experts guiding the scientific and organisational direction of ICPOC 2026.

Prof. David Williams Conference Chair

Pioneer in precision oncology with 25+ years leading translational research. Author of 300+ peer-reviewed publications.

Prof. David Williams

Conference Chair

Harvard Medical School, USA

Precision Oncology Translational
Dr. Sarah Chen Scientific Chair

Leading liquid biopsy researcher in Asia-Pacific. PI on multiple national cancer screening trials in Singapore.

Dr. Sarah Chen

Scientific Chair

National Cancer Centre, Singapore

Liquid Biopsy Early Detection
Prof. Hiroshi Tanaka Co-Chair

CAR-T cell therapy innovator with clinical programmes adopted across Japan and South Korea. Keynote at 40+ conferences.

Prof. Hiroshi Tanaka

Co-Chair

University of Tokyo, Japan

CAR-T Therapy Immunotherapy
Prof. Robert Mueller Programme Director

Expert in clinical trial design and regulatory science for oncology therapeutics with over 20 years of experience.

Prof. Robert Mueller

Programme Director

Charité Berlin, Germany

Clinical Trials Regulatory
Dr. Amira Hassan Abstract Chair

Specialist in cancer care delivery in resource-limited settings across South Asia. Leads abstract review for ICPOC 2026.

Dr. Amira Hassan

Abstract Chair

Aga Khan University, Pakistan

Health Equity Public Health
Dr. Li Wei Workshop Director

Nanomedicine and targeted drug delivery systems researcher with pioneering work in nanoparticle-based therapeutics.

Dr. Li Wei

Workshop Director

Peking Union Hospital, China

Nanomedicine Drug Delivery
Prof. Elena Russo Scientific Committee

Targeted therapy resistance mechanisms in melanoma and solid tumours. Leading European oncology voice.

Prof. Elena Russo

Scientific Committee

European Institute of Oncology, Italy

Targeted Therapy Melanoma
Prof. Samuel Osei International Liaison

Building oncology research capacity across Sub-Saharan Africa. Leads collaborative programmes across 12 African nations.

Prof. Samuel Osei

International Liaison

University of Ghana, Ghana

Global Oncology Capacity Building

Distinguished Faculty

International experts spanning all major oncology disciplines.

Prof. James Harper USA

Leading authority on genomic profiling in solid tumours.

Prof. James Harper

Genomic Profiling

Mayo Clinic, USA

Dr. Meera Patel India

Pioneer in affordable precision diagnostics for South Asia.

Dr. Meera Patel

Precision Diagnostics

Tata Memorial, India

Dr. John Kim South Korea

AI and machine learning in oncology imaging and diagnostics.

Dr. John Kim

AI in Oncology

Samsung Medical, Korea

Prof. Elena Russo Italy

Targeted therapy resistance mechanisms in melanoma.

Prof. Elena Russo

Targeted Therapy

European IO, Italy

Prof. Yuki Sato Japan

Minimally invasive surgical oncology techniques and outcomes.

Prof. Yuki Sato

Surgical Oncology

Osaka University, Japan

Dr. Carlos Mendez Brazil

Cancer care equity in low-resource settings globally.

Dr. Carlos Mendez

Global Oncology

INCA, Brazil

3-Day Programme at a Glance

A provisional overview of sessions across all three days. The final schedule will be confirmed closer to the event.

Note: This is a provisional schedule subject to change. View the full scientific programme →
08:30 - 09:00
Opening
Opening Ceremony & Welcome Address

Prof. David Williams — Harvard Medical School, USA

09:00 - 09:45
Keynote
The Precision Oncology Revolution: From Bench to Bedside

Prof. David Williams — Harvard Medical School, USA

10:45 - 11:30
Plenary
Liquid Biopsy in Early Cancer Detection: A New Paradigm

Dr. Sarah Chen — National Cancer Centre, Singapore

14:00 - 14:45
Keynote
Genomic Profiling in Solid Tumours: 2026 Clinical Update

Prof. James Harper — Mayo Clinic, USA

18:00 - 20:00
Networking
Welcome Reception & Networking

SkyPark Observation Deck — All delegates welcome

08:30 - 09:30
Keynote
CAR-T Cell Therapy: Clinical Milestones and Future Directions

Prof. Hiroshi Tanaka — University of Tokyo, Japan

09:30 - 10:15
Keynote
Artificial Intelligence & Machine Learning in Oncology Imaging

Dr. John Kim — Samsung Medical Centre, South Korea

10:45 - 11:30
Plenary
Targeted Therapy Resistance Mechanisms in Melanoma

Prof. Elena Russo — European Institute of Oncology, Italy

11:30 - 13:00
Workshop
Workshop: Nanomedicine & Targeted Drug Delivery

Dr. Li Wei — Peking Union Hospital, China

14:00 - 14:45
Plenary
Affordable Precision Diagnostics for South Asia

Dr. Meera Patel — Tata Memorial Hospital, India

17:00 - 18:00
Panel
Future of Global Cancer Care: Equity, Access & Innovation

Moderated Panel — Multiple Speakers

09:30 - 10:15
Plenary
Cancer Care Equity in Low- and Middle-Income Countries

Dr. Carlos Mendez — INCA, Brazil

10:15 - 11:00
Keynote
Palliative Care Integration in Oncology: A Global Perspective

Dr. Fatima Khalid — King Saud University, Saudi Arabia

11:30 - 13:00
Workshop
Workshop: Survivorship Care Planning

Multiple Facilitators

15:00 - 15:45
Awards
Best Abstract Awards Ceremony

Oral & Poster Categories — Main Auditorium

15:45 - 16:30
Closing
Closing Ceremony & Farewell

Prof. David Williams — Harvard Medical School, USA

Watch Our Story

Experience the impact of ICPOC through highlights from previous editions.

Proudly Supported By

Global leaders in oncology, pharmaceuticals, and medical technology partnering with ICPOC 2026.

Exhibition Opportunities

Showcase your products and services to 1,500+ oncology professionals from 50+ countries.

Platinum Package

$15,000

Premier visibility

  • 12 sqm exhibition booth
  • 5 delegate passes
  • Keynote session branding
  • Full-page ad in programme
  • Logo on all materials
Enquire Now

Gold Package

$8,000

High exposure

  • 9 sqm exhibition booth
  • 3 delegate passes
  • Half-page ad in programme
  • Logo on website
  • Social media mentions
Enquire Now

Silver Package

$4,000

Solid presence

  • 6 sqm exhibition booth
  • 2 delegate passes
  • Quarter-page ad
  • Logo on website
  • Brochure distribution
Enquire Now

Bronze Package

$2,000

Entry visibility

  • 3 sqm table-top display
  • 1 delegate pass
  • Logo on website
  • Flyer in conference bag
  • Networking access
Enquire Now

Get Past Conference Information

Explore highlights, resources, and materials from previous ICPOC editions.

Jumeirah Beach Hotel · March 15–17, 2024

1,200+ Attendees 65 Speakers 42 Nations

Focused on advances in immunotherapy, precision diagnostics, and cancer care delivery across the Middle East and Asia.

Centara Grand · October 20–22, 2023

950+ Attendees 55 Speakers 38 Nations

Emphasised Asia-Pacific oncology challenges, emerging therapies, and building collaborative research networks across Southeast Asia.

Online Platform · September 8–10, 2022

2,100+ Attendees 72 Speakers 61 Nations

Our largest virtual edition connected oncology professionals globally during a pivotal time, with all sessions available on-demand post-event.

What Our Community Says

Frequently Asked Questions

Can't find what you're looking for? Reach out to our secretariat.

Ask a Question Download Brochure

ICPOC 2026 is open to oncologists, haematologists, cancer researchers, nurses, allied health professionals, students, and industry representatives from all countries. Both in-person and virtual attendance options are available.

The abstract submission deadline is August 30, 2026. Abstracts submitted after this date may not be considered. Notifications of acceptance will be sent by September 20, 2026. We encourage early submission to allow time for revisions.

Early bird registration closes on September 15, 2026. Delegates registering before this date receive significant discounts. Group registrations (3+ participants) receive an additional 30% discount. We recommend booking early as places are limited.

Yes. ICPOC 2026 is fully CPD accredited by the Joint Accreditation Committee for Continuing Professional Development (JACCPD), offering delegates up to 15 CME credits. Certificates are issued electronically within 14 days of the event.

Visa requirements vary by nationality. Singapore offers visa-free entry to citizens of many countries. We can provide official invitation letters to registered delegates to support visa applications. Please contact our secretariat well in advance, ideally 8–10 weeks before the event.

Yes. ICPOC 2026 is a hybrid conference. Virtual delegates receive live access to all plenary and keynote sessions, on-demand viewing for 30 days post-event, access to the virtual networking platform, and a digital certificate with CME credits. The virtual registration fee is significantly lower than in-person attendance.